99mTc-monoclonal antibody radiolabeled via hydrazino nicotinamide derivative for imaging disialoganglioside G(D2)-positive tumors

Nuclear Medicine and Biology

Volumn 26, Issue 6, 1999, Pages 681-686

  Fonti, Rosa ^a   Cheung, Nai Kong V ^a   Bridger, Gary J ^b   Guo, Hong Fen ^a   Abrams, Michael J ^b   Larson, Steven M ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b GENZYME CORPORATION   (United States)

Author keywords

3F8; 99mTc labeling; Biodistribution; Imaging; Monoclonal antibody; SHNH

Indexed keywords

GANGLIOSIDE GD2; IMMUNOGLOBULIN G3; MONOCLONAL ANTIBODY; SUCCINYLIMIDYL 6 HYDRAZINONICOTINATE; TECHNETIUM 99M; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; GANGLIOSIDE; GANGLIOSIDE, GD2; NICOTINAMIDE; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; SUCCINIMIDE DERIVATIVE; SUCCINIMIDYL 6 HYDRAZINONICOTINATE; SUCCINIMIDYL 6-HYDRAZINONICOTINATE; TECHNETIUM COMPLEX;

ARTICLE; CONTROLLED STUDY; DRUG DISTRIBUTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOSCINTIGRAPHY; ISOTOPE LABELING; NEUROBLASTOMA CELL; TUMOR; ANIMAL; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; MOUSE; NEUROBLASTOMA; NUDE MOUSE; SCINTISCANNING; TISSUE DISTRIBUTION; XENOGRAFT;

ANIMALS; ANTIBODIES, MONOCLONAL; GANGLIOSIDES; HUMANS; IODINE RADIOISOTOPES; MICE; MICE, NUDE; NEUROBLASTOMA; NIACINAMIDE; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; SUCCINIMIDES; TISSUE DISTRIBUTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 0032590047     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0969-8051(99)00026-8     Document Type: Article

References (39)

1. Abrams M.J., Juweid M., tenKate C.I., Schwartz D.A., Hauser M.M., Gaul F.E., Fuccello A.J., Rubin R.H., Strauss H.W., Fischman A.J. Technetium-99m-human polyclonal IgG radiolabeled via the hydrazino nicotinamide derivative for imaging focal sites of infection in rats. J. Nucl. Med. 31:1990;2022-2028.
2. Arbit E., Yeh S.J., Cheung N.K., Larson S.M. Quantitative Immunoimaging of gliomas in humans with anti-ganglioside monoclonal antibodies [abstract]. J. Neurosurg. 76:1991;399.
3. Barrow S.A., Graham W., Jyawook S., Dragotakes S.C., Solomon H.F., Babich J.W., Rubin R.H., Fischman A.J. Localization of indium-111-immunoglobulin G, technetium-99m-immunoglobulin G and indium-111-labeled with blood cells at sites of acute bacterial infection in rabbits. J. Nucl. Med. 34:1993;1975-1979.
4. Blauenstein P., Locher J.T., Seybold K., Koprivova H., Janoki G.A., Mache H.R., Hasler P., Ammann A., Novak-Hofer I., Smith A., Schubiger P.A. Experience with the iodine-123 and technetium-99m labelled anti-granulocyte antibody Mab47 A comparison of labelling methods . Eur. J. Nucl. Med. 22:1995;690-698.
5. Boonkitticharoen V., James H., Cheung N.K.V., Larson S.M., Finn R.D. Optimizing the recovery of chemically reduced monoclonal antibody for site specific technetium-99m radiolabeling. Biotechniques. 14:1993;706-707.
6. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-274.
7. 99mTc and radioiodine. Cancer Res. 54:1994;4162-4168.
8. Callahan R.J., Barrow S.A., Abrams M.J., Rubin R.H., Fischman A.J. Biodistribution and dosimetry of technetium-99m-hydrazino nicotinamide IgG Comparison with indium-111-DTPA-IgG . J. Nucl. Med. 37:1996;843-846.
9. Chang H.R., Cordon-Cardo C., Houghton A.N., Cheung N.K.V., Casper E.S., Brennan M.F. Expression of disialogangliosides GD2 and GD3 by human soft tissue sarcomas. Cancer. 70:1992;633-638.
10. Cheung N.K., Landmeier B., Neely J., Nelson D., Abramowsky C., Ellery S., Adams R., Miraldi F.D. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2 specific monoclonal antibody against human neuroblastoma xenografted in nude mice. J. Natl. Cancer Inst. 77:1986;739-745.
11. D2 monoclonal antibody to neuroblastoma. J. Nucl. Med. 28:1987;1577-1583.
12. Cheung N. K., Pentlow K., Graham M. C., Yeh S. D. J., Finn R. D. and Larson S. M. (1992) Radioimmunotherapy of human neuroblastoma using monoclonal antibody 3F8. In: Fifth International Radiopharmaceutical Dosimetry Symposium, pp. 95-112. Oak Ridge Associated Universities, Oak Ridge, TN.
13. Cheung N.K., Saarinen U.M., Neely J.E., Landmeier B., Donovan D., Coccia P.F. Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells. Cancer Res. 45:1985;2642-2649.
14. Childs R.L., Hnatowich D.J. Optimum conditions for labeling of DTPA-coupled antibodies with technetium-99m. J. Nucl. Med. 26:1985;293-299.
15. Desphande S.V., DeNardo S.J., Meares C.F. Copper-67-labeled monoclonal antibody LYM-1 a potential radiopharmaceutical. J. Nucl. Med. 29:1988;217-225.
16. 99mTc. Nucl. Med. Biol. 16:1989;171-176.
17. Fraker P.J., Speck J.C. Protein and cell membrane iodinations with a sparingly soluble chloramide, 1,3,4,6-tetrachloro-3a,6a-diphenylglycoluril. Biochem. Biophys. Res. Commun. 80:1978;849-857.
18. Fritzberg A.R., Abrams P.G., Beaumier P.L., Kasina S., Morgan A.C., Rao T.N., Reno J.M., Sanderson J.A., Srinavasan A., Wilbur D.S., Vanderheyden J.L. Specific and stable labeling of antibodies with technetium-99m with a diamide dithiolate chelating agent. Proc. Natl. Acad. Sci. USA. 85:1988;4025-4029.
19. Furukawa K., Akagi T., Nagata Y., Yamada Y., Shimotohno K., Cheung N.K.V., Shiku H., Furukawa K. GD2 ganglioside on human T lymphotropic virus type I-infected T cells Possible activation of beta-1,4N-acetylgalactosaminyl-transferase gene by p40-tax . Proc. Natl. Acad. Sci. USA. 90:1993;1972-1976.
20. Grant S.C., Kostakoglu L., Kris M.G., Yeh S., Larson S.M., Finn R.D., Oettgen H.F., Cheung N.K.V. Radioimmunodetection of small-cell lung cancer using the anti-GD2 ganglioside monoclonal antibody 3F8 A pilot trial . Eur. J. Nucl. Med. 23:1996;145-149.
21. Heiner J., Miraldi F.D., Kallick S., Makley J., Smith-Mensah W.H., Neely J., Cheung N.K.V. In vivo targeting of GD2 specific monoclonal antibody in human osteogenic sarcoma xenografts. Cancer Res. 47:1987;5377-5381.
22. Hiltunen J.V. Search for new and improved radiolabeling methods for monoclonal antibodies. Acta Oncol. 32:1993;831-839.
23. Hnatowich D.J., Mardirossian G., Rusckowski M., Fogarasi M., Virzi F., Winnard P. Jr. Directly and indirectly technetium-99m-labeled antibodies - A comparison of in vitro and animal in vivo properties. J. Nucl. Med. 34:1993;109-119.
24. Kozak R.W., Raubitschek A., Mirzadeh S., Brechbiel M.W., Junghaus R., Gansow O.A., Waldman T.A. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies Critical factors in determining in vivo survival and organ toxicity . Cancer Res. 49:1989;2639-2644.
25. 99mTc Tricine A useful precursor complex for the radiolabeling of hydrazinonicotinate protein conjugates . Bioconjug. Chem. 6:1995;635-638.
26. Larson S.M., Sgouros G., Cheung N.K. Antibodies in cancer therapy Radioisotope conjugates . DeVita V.T., Hellman S., Rosenberg S.A. Biologic Therapy of Cancer. 2nd edn :1995;534-552 J.B. Lippincott, Philadelphia.
27. Mather S.J., Ellison D. Reduction-mediated technetium-99m labeling of monoclonal antibodies. J. Nucl. Med. 31:1990;692-697.
28. Miraldi F.D., Nelson A.D., Kraly C., Ellery S., Landmeier B., Coccia P.F., Strandjord S.E., Cheung N.K.V. Diagnostic imaging of human neuroblastoma with radiolabeled antibody. Radiology. 161:1986;413-418.
29. Moffat R., Pinsky C.M., Hammershaimb L., Petrelli N.J., Patt Y.Z., Whaley F.S., Goldenberg D.M. Clinical utility of external immunoscintigraphy with the IMMU-4 technetium-99m Fab′ antibody fragment in patients undergoing surgery for carcinoma of the colon and rectum Results of a pivotal, phase III trial. The Immunomedics Study Group . J. Clin. Oncol. 14:1996;2295-2305.
30. Ram S., Buchsbaum D.J. A peptide-based bifunctional chelating agent for Tc-99m and Re-186 labeling of monoclonal antibodies. Cancer. 73:1994;769-773.
31. Rhodes B.A., Zamora P.O., Newell K.D., Valdez E.F. Technetium-99m labeling of murine monoclonal antibody fragments. J. Nucl. Med. 27:1994;685-693.
32. Rubin R.H., Fischman A.J., Needleman M., Wilkinson R., Callahan R.J., Khaw B., Hansen W.P., Kramer P.B., Strauss H.W. Ridiolabeled, non-specific, polyclonal human immunoglobulin in the detection of focal inflammation by scintigraphy Comparison with gallium-67 citrate and technetium-99m-labeled albumin . J. Nucl. Med. 30:1989;385-389.
33. Schwartz A., Steinstrasser A. A novel approach to Tc-99m-labeled monoclonal antibodies [abstract]. J. Nucl. Med. 28:1987;721.
34. 99mTc-protein conjugates. Bioconjug. Chem. 2:1991;333-336.
35. Thakur M.L., DeFulvio J.D. Technetium-99m-labeled monoclonal antibodies for immunoscintigraphy. J. Immunol. Methods. 137:1991;217-223.
36. Thakur M.L., Kolan H.R., Rifat S., Li J., Rux A., John E., Halmos G., Schally A.V. Valpreotide labeled with Tc-99m for imaging tumors Preparation and preliminary evaluation . Int. J. Oncol. 9:1996;445-451.
37. Weinstein J.N., Eger R.R., Covell D.G., Larson S.M., Keenam A.M. The pharmacology of monoclonal antibodies. Ann. NY Acad. Sci. 507:1987;199-210.
38. Yeh S.D., Larson S.M., Burch L., Kushner B.H., LaQuaglia M., Finn R., Cheung N.K.V. Radioimmunodetection of neuroblastoma with iodine-131-3F8 Correlation with biopsy, iodine-131-Metaiodobenzylguanidine (MIBG) and standard diagnostic modalities . J. Nucl. Med. 32:1991;769-776.
39. Zhang S., Filippa D.A., Zhang H.S., Zelenetz A., Scheinberg D., Livingston P. Expression of GM2 and GD2 in B cell lymphomas Targets for immune attack [abstract] . Proc. Am. Assoc. Cancer Res. 38:1997;404.